11.88
+2.77%
Close of 9 Nov 2026, in CAD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$10.45bn
FY2016FY2025
Net income
$159.7m
FY2016FY2025
Free cash flow
$974.8m
FY2016FY2025
Shareholders' equity
−$553.0m
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.45bn | $9.63bn | $8.76bn | $8.12bn | $8.43bn | $8.03bn | $8.60bn | $8.38bn | $8.72bn | $9.67bn |
| Research and development | $640.0m | $616.0m | $604.0m | $529.0m | $465.0m | $452.0m | $471.0m | $414.0m | $366.0m | $455.0m |
| Operating income | $1.93bn | $1.55bn | $963.0m | $1.37bn | $1.21bn | $676.0m | −$73.0m | −$2.29bn | $102.0m | −$566.0m |
| Net income | $159.7m | −$46.0m | −$592.0m | −$212.0m | −$937.0m | −$559.0m | −$1.78bn | −$4.15bn | $2.40bn | −$2.41bn |
| Diluted earnings per share | 0.43 | -0.12 | -1.67 | -0.58 | -2.57 | -1.56 | -4.96 | -11.86 | 6.79 | -6.89 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $26.32bn | $26.52bn | $27.35bn | $25.69bn | $29.20bn | $31.20bn | $33.86bn | $27.45bn | $37.50bn | $43.53bn |
| Cash and short-term investments | $1.32bn | $1.18bn | $947.0m | $564.0m | $582.0m | $605.0m | $3.24bn | $721.0m | $720.0m | $542.0m |
| Total liabilities | $25.94bn | $26.84bn | $27.43bn | $25.43bn | $29.24bn | $30.59bn | $32.73bn | $24.63bn | $31.55bn | $40.27bn |
| Debt | $21.21bn | $21.62bn | $22.39bn | $20.77bn | $22.65bn | $25.16bn | $25.89bn | $24.63bn | $25.44bn | $29.85bn |
| Shareholders' equity | −$553.0m | −$1.28bn | −$1.02bn | −$692.0m | −$106.0m | $535.0m | $1.06bn | $2.73bn | $5.85bn | $3.15bn |
| Shares outstanding | 371m | 372m | 355m | 363m | 364m | 359m | 359m | 350m | 354m | 350m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $1.38bn | $1.60bn | $1.03bn | −$728.0m | $1.43bn | $1.11bn | $1.50bn | $1.50bn | $2.29bn | $2.09bn |
| Capital spending | −$403.9m | −$340.0m | −$272.0m | −$268.0m | −$283.0m | −$309.0m | −$278.0m | −$235.0m | −$336.0m | −$291.0m |
| Free cash flow | $974.8m | $1.26bn | $760.0m | −$996.0m | $1.14bn | $802.0m | $1.22bn | $1.27bn | $1.95bn | $1.80bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.78bn | $2.48bn | $2.84bn | $912.0m | $2.53bn | $2.26bn | $2.56bn | $2.51bn |
| Operating income | $755.0m | $512.5m | $730.1m | $619.0m | $444.0m | $276.0m | $558.0m | $318.0m |
| Net income | $251.3m | −$1.40bn | −$113.7m | $179.0m | $148.0m | −$58.0m | $93.0m | −$85.0m |
| Diluted earnings per share | 0.66 | -3.70 | -0.31 | 0.48 | 0.40 | -0.16 | 0.25 | -0.23 |
| Cash from operations | $670.0m | $230.0m | $495.0m | $405.0m | $289.0m | $211.0m | $601.0m | $405.0m |
| Capital spending | −$77.0m | −$147.0m | −$93.0m | −$91.0m | −$100.0m | −$124.0m | −$107.0m | −$71.0m |
| Free cash flow | $593.0m | $83.0m | $402.0m | $314.0m | $189.0m | $87.0m | $494.0m | $334.0m |
| Total assets | $24.79bn | $24.50bn | $26.32bn | $26.80bn | $27.27bn | $26.42bn | $26.52bn | $26.54bn |
| Cash and short-term investments | $1.82bn | $1.30bn | $1.32bn | $1.34bn | $1.73bn | $1.13bn | $1.18bn | $719.0m |
| Debt | $20.76bn | $20.77bn | $20.91bn | $21.04bn | $21.74bn | $21.51bn | $21.62bn | $21.51bn |
| Shareholders' equity | −$1.77bn | −$2.06bn | −$553.0m | −$564.4m | −$764.0m | −$1.18bn | −$1.28bn | −$1.17bn |
Financial ratios
Data as of 29 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | 21.3% | 16.2% | 10.7% | 18.3% | 20.3% | 7.5% |
| Net margin | 1.5% | -0.5% | -6.8% | -2.6% | -11.1% | -7.0% |
| Return on equity | -28.9% | 3.6% | 57.9% | 30.6% | 884.0% | -104.5% |
| Return on assets | 0.6% | -0.2% | -2.2% | -0.8% | -3.2% | -1.8% |
| Free cash flow yield | 49.8% | 53.8% | 38.0% | -13.1% | 48.5% | 40.9% |
| Revenue growth | 8.5% | 9.9% | 7.8% | -3.7% | 5.1% | -6.7% |
| Earnings growth | -447.3% | -92.2% | 179.2% | -77.4% | 67.6% | -68.6% |
| Current ratio | 1.47x | 0.86x | 1.30x | 1.08x | 1.08x | 1.09x |
| Debt to equity | -37.77x | -16.95x | -21.97x | -30.08x | -214.78x | 47.03x |
| Equity ratio | -2.1% | -4.8% | -3.7% | -2.7% | -0.4% | 1.7% |
| Interest coverage | 1.35x | 1.12x | 0.71x | 1.01x | 1.20x | 0.39x |
| R&D as a share of sales | 6.1% | 6.4% | 6.9% | 6.5% | 5.5% | 5.6% |
| Buybacks as a share of market value | 0.4% | -4.9% | 2.3% | 0.3% | -1.4% | 0.1% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 8.7% | 5.4% | -0.1% |
| Operating income | 12.1% | 23.3% | 2.2% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 17.4% | 15.7% | 14.4% | 6.5% |
| Net margin | 0.6% | -1.9% | -4.1% | -8.4% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Price to earnings | 16.1 | -68.6 | -4.7 | -10.6 | -4.9 | -6.1 |
| Price to sales | 0.3 | 0.3 | 0.3 | 0.3 | 0.5 | 0.4 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 10 Nov 2010.
| FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 | |
|---|---|---|---|---|---|---|
| Paid in the year | 1.28 | 0.645 | 1.50 | 1.50 | 1.00 | 0.50 |
- 2-for-1 split · 5 Oct 2000
- 2-for-1 split · 10 Jan 2000
- 3-for-1 split · 8 Jan 1996
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.